Goa, April 19, 2024: HCG, one of India’s largest cancer care networks, has launched OPD consultations in Goa, extending its expert oncology services to the region. A dedicated team of oncologists from HCG Cancer Hospital Bangalore, will conduct consultations twice a month at two locations: the Campal Clinic in Panjim and the Royal Hospital in Margao. This initiative aims to provide world-class cancer care to patients in Goa, offering access to specialized treatments and expert oncologists.
In conducting these OPD sessions, HCG strives to advance early cancer diagnosis, raise cancer awareness, enhance medical accessibility, and present diverse treatment options in Goa. By prioritizing swift diagnosis and treatment, HCG demonstrates its commitment to enhancing cancer care in the region, reflecting an innovative and patient-centric approach.
Renowned for its comprehensive cancer treatment offerings, HCG Cancer Hospital Bangalore delivers cutting-edge immunotherapy, robotic surgery, liver, and bone marrow transplants, Cyberknife procedures, and personalized genomics services.
Ms. Manisha Kumar, Regional Chief Operating Officer Karnataka, Healthcare Global Enterprises Limited said “As we launch OPD consultations in Goa, we at HCG are committed to extending our expert oncology services to the region. With a dedicated team of oncologists from HCG Cancer Hospital Bangalore, we aim to provide world-class cancer care to patients in Goa, ensuring access to specialized treatments and expert guidance without the inconvenience of travelling outside Goa. With this initiative, patients in Goa will receive optimal care and benefit from the latest advancements in cancer treatment and we look forward to making a positive impact in the region.”
HCG Cancer Hospital Bangalore is known for its advanced treatment methods, state-of-the-art diagnostic and treatment equipment, and outstanding patient results, delivering exemplary care to millions since its establishment. With cutting-edge technology for cancer diagnosis and treatment, including nuclear medicine, PET-CT, genomics, and low-dose immunotherapy, the hospital prioritizes a patient-centric approach.
